| Pharmaceutical active ingredients: |
| Cyclophosphamide Monohydrate |
| Available forms, composition and doses of Ledoxina: |
| Dragee; Oral; Cyclophosphamide Monohydrate 50 mgInjectable; Injection; Cyclophosphamide Monohydrate 100 mgInjectable; Injection; Cyclophosphamide Monohydrate 1000 mgInjectable; Injection; Cyclophosphamide Monohydrate 200 mgInjectable; Injection; Cyclophosphamide Monohydrate 500 mg |
| Ledoxina medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01AA01 - Cyclophosphamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| TevaChile LaboratoriosLemery |